Increase funding and support for vaccine research and deployment to ensure rapid response to emerging infectious diseases.
Pandemics
Pandemics Risk
Assessment for this date
Today's pandemic risk is moderate due to ongoing infectious disease outbreaks, including avian flu and MERS, coupled with challenges in vaccine deployment and misinformation.
June 3, 2026
Trend
Viewing the record for June 3, 2026 within the full trend.
Risk Drivers
What is pushing the current reading.
The current global health landscape is marked by multiple infectious disease threats, including avian flu outbreaks in the US and Europe, and MERS cases in the Middle East. These outbreaks highlight the potential for zoonotic diseases to spread across borders. Concurrently, misinformation and vaccine hesitancy, particularly around COVID-19 and other vaccines, continue to undermine public health efforts. The development and deployment of vaccines are ongoing, but gaps in coverage and public trust remain significant hurdles. Additionally, the emergence of new virus strains and the persistence of long COVID symptoms in a significant portion of the population add complexity to the public health response.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance surveillance systems to detect and respond to zoonotic diseases and new virus strains promptly.
Promote accurate information about vaccines and counter misinformation to improve public trust and vaccine uptake.
Educate patients about the benefits of vaccination and the risks of infectious diseases to reduce vaccine hesitancy.
Strengthen global collaboration and resource sharing to address cross-border infectious disease threats effectively.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- Avian flu hits 4 US poultry farms, polar bear on Norway island
- WHO reports H5N1 death among variant zoonotic flu cases seen this year
- Saudi Arabia confirms 9 MERS cases, including hospital cluster
- COVID vaccine may boost antibody response to MERS, other coronaviruses
- Vaccine skepticism now the norm for many Americans